. Children in the empyema group had significantly more dyspnea symptoms than the children with PPE (p=0.022). Mean fever duration before hospitalization was similar in both groups. Streptococcus pneumoniae and group A streptococcus were the most common causes of empyema. All of the patients were treated with intravenous antibiotics. In addition to medical treatment, tube thoracostomy was performed in 59 of 70 (84.3%) patients in empyema group; 27 (45.8%) of them required intrapleural fibrinolysis also. In the presence of antibiotic treatment failure or in cases with moderate or large pleural effusion with loculations and clinical deterioration; it is necessary to perform drainage of the purulent fluid by tube thoracostomy, to add intrapleural fibrinolytics or to perform video-assisted thoracoscopic surgery (VATS), in order to enhance prompt recovery.
Parapneumonic effusion (PPE) and empyema are most often seen as a complication of bacterial pneumonia and occasionally associated with atypical bacterial or viral pneumonia. Parapneumonic effusion is an exudate within the pleural space associated with underlying pneumonia. Parapneumonic effusions have traditionally been classified into three categories, which can be thought of as different stages from a continuum disease spectrum: uncomplicated PPEs, complicated PPEs, and empyemas. The term uncomplicated PPE denotes an effusion that resolves with the antibiotic therapy prescribed for pneumonia. Complicated PPEs require drainage of pleural fluid by the interventions of repeated thoracentesis, thoracostomy tube drainage, fibrinolysis, video-assisted thoracoscopic surgery (VATS) and open thoracotomy for cure, in addition to antibiotics [1] [2] [3] [4] . Empyema is characterized as the aspiration of pus by thoracentesis and is considered the last stage of a PPE; as such, it must always be drained. Therefore, empyemas are, by definition, complicated PPEs. Streptococcus pneumoniae is the most common agent of empyema in all ages beyond the neonatal period 3, 5 . After the introduction of conjugated Haemophilus influenzae type B and conjugated pneumococcal vaccine in childhood vaccination schedule, methicillin-sensitive Staphylococcus aureus (MSSA), community acquired methicillin-resistant S. aureus (MRSA) and Streptococcus pyogenes are becoming increasingly frequent organisms. Optimal management of PPE is currently controversial. The aims of this study were to describe and compare demographic characteristics, clinical, laboratory, microbiological findings and treatment modalities for hospitalized patients with the diagnosis of PPE or pleural empyema.
Material and Methods
We retrospectively evaluated consecutive patients with PPE and pleural empyema who were admitted to our hospital from January 2006 to June 2015. Posteroanterior chest X-ray and ultrasound imaging were available for all of the patients. Chest CT had been performed for the patients with the suspicion of necrotizing pneumonia, parenchymal abscesses or bronchopleural fistulae. Diagnostic thoracentesis had been performed in patients who had pleural fluid on ultrasound imaging more than 1 cm. The terms of PPE and pleural empyema were based on pleural fluid findings except patients who had <1 cm pleural fluid suggestive of empyema with ultrasonographic view. Pleural empyema was defined as purulent pleural fluid appearance. In addition to purulent appearance, the presence of a pleural fluid pH <7.20, a glucose level <40 mg/dl and a lactate dehydrogenase (LDH) level >1000 IU and/or positive Gram stain and/or positive pleural fluid cultures. Uncomplicated PPE was defined as: if the aspirated fluid is nonpurulent, and having pH >7.20, glucose level >40 mg/ dl, LDH level <1000 IU, negative Gram stain and negative pleural fluid cultures.
The medical records of patients were reviewed in respect of age, sex, history of cough, dyspnea, chest pain, abdominal pain, physical examination findings and previous antibiotic treatment before hospitalization. 
months (IQR 12 months).

Discussion
Parapneumonic effusion is a known complication of mainly bacterial pneumonia in children. Viral or mycoplasmal pneumonia may also cause PPE with a ratio of up to 20%. The incidence of PPE and empyema is steadily increasing according the recent reports. Empyema has been reported in 6.3 to 23 of 1,000 admissions among children 6, 7 . After the PCV7 introduction, despite rates of bacterial pneumonia and invasive pneumococcal disease decreased, annual empyema associated hospitalization rates in children increased. Authors thought that this is likely the result of serotype replacement with non-vaccine serotypes, or increasing MRSA 8, 10 . In the present study; we could not compare the two groups with respect of PCV7 or PCV13, since the patients of both groups were vaccinated partly and heterogeneously PCV7 or PCV13.
Parapneumonic effusion and empyema are more common in boys than girls and are more frequently encountered in infants and young children 11 . Number of girls and boys were similar for patients with PPE and empyema in the present study. The median age at presentation of patients with empyema, was lower than the patients with PPE in our study. A comparison had been made between hospitalized patients with community acquire pneumonia (CAP) and empyema in a United States of America (USA) study. Empyema had been reported in 153 of 540 (28.3%) children with pneumonia. In concordance with our results, patients with empyema were more likely to be older than 3 years in this study 12 .
The present study did not include patients with CAP.
The presenting symptoms of PPE are frequently subtle and usually similar with classic symptoms of pneumonia such as cough, dyspnea, fever, malaise, loss of appetite. The clinical features of empyema are fever, cough, dyspnea tachypnea, lethargy, increasing oxygen requirement and respiratory distress. Pleural and abdominal pain were also seen 13 . Fever was the most common presenting symptom of children with PPE and empyema in our study. All other presenting symptoms except dyspnea were similar in both groups. Dyspnea is more significant in patients with empyema than patients with PPE. It was reported that children with empyema had more chest pain and dyspnea at admission and had a significantly longer duration of fever compared with effusion and CAP group in the pediatric studies 2, 11, 14, 15 . On the contrary; mean duration of fever before hospitalization was similar in both groups in our study. We thought that two groups of our study had complicated or 2, 17 . Streptococcus pneumoniae is the most common cause of CAP with or without empyema. Pleural empyema develops in 75% of patients with S. aureus pneumonia. The incidence of Hib empyema decreased after the introduction of the Hib vaccination. Group A streptococcus, other streptococcal species, M. pneumoniae and gram-negative organisms are less common causes of empyema in children.
Recently community acquired MRSA has been found to be an important causative organism of empyema 2, 7, 13, [16] [17] [18] [19] . In our study, S. pneumoniae was the most common pathogen, followed by group A streptococcus. In a recent multicenter study from Turkey, S. pneumoniae serotypes were determined in 156 children with empyema, irrespective of their vaccination status. S. pneumoniae was detected in 53 of 156 patients (34%) by PCR and serotypes were specified in 33 of them. The most common pneumococcal serotypes in this study were 1 and 5, which are covered by both PCV10 and PCV13, but serotype 3 is covered only by PCV-13 20 . Defined serotypes of five of our patients, as a part of this laboratory-based surveillance, are 1, 3, 4, 5, and14.
Mycoplasma pneumoniae is one of the most common respiratory pathogens. The course of illness is usually benign and is rarely associated with pulmonary complications. PPE due to M. pneumoniae has been reported in 4-20% of patients with CAP. Although PPE is generally small, unilateral and does not require chest tube insertion, it can be massive and bilateral 1, [21] [22] [23] [24] [25] . In a retrospective observational study involving 121 hospitalized children and adolescent patients with CAP/ PPE, M. pneumoniae without co-infection was detected in 34 and M. pneumoniae/S. pneumoniae co-infection was found in nine patients. Other responsible organisms were reported as S. pneumoniae in 36 and S. aureus in 31 patients. Authors concluded that M. pneumoniae related PPE was milder than that was caused by other organisms, but its course was longer 26 . Massive pleural effusion and empyema secondary to M. pneumoniae infection has been reported as case series or single case reports 5, [27] [28] [29] [30] [31] [32] . In our study, M. pneumoniae related empyema and PPE were required chest tube drainage and tube thoracostomy with intrapleural fibrinolysis that M. pneumoniae related empyema and PPE might be massive.
Diagnostic imaging methods play an important role in the diagnosis and management of PPE and empyema. The principal imaging methods are chest X-ray, chest ultrasonography, and chest CT. Posteroanterior or anteroposterior chest X-ray is frequently used as the first investigation method to suggest the presence of a parapneumonic collection, however it cannot definitively establish the presence of empyema. Chest ultrasonography confirms the presence of a pleural fluid and it useful to detect amount of fluid, fibrinous septations, debris or loculations in the pleural space. It may be also used to guide thoracentesis or drain placement 11, 33 . Some authors suggest that pleural debris, loculations and septations are better identified by using ultrasonography rather than CT scan 34, 35 . In a study of 30 pediatric patients, CT scanning was not found so helpful in differentiating empyema from PPE 36 . The authors suggested that chest CT scan should not be performed routinely for the diagnosis of empyema or PPE. A small retrospective review comparing USG and CT found that CT had no advantage in most cases. Authors considered that CT should be used for distinguishing parenchymal abscesses from empyema or to detect broncho-pleural fistulae as a complication of empyema 35 . In our study chest USG was a primary choice of imaging.
In the present study, the chest CT scan was found useful to detect necrotizing pneumonia and lung abscesses. The common fibrinolytic agents are urokinase, streptokinase and tissue plasminogen activator (tPA). In retrospective and prospective studies, fibrinolytic therapy has been shown to be superior to chest tube drainage alone when chest tube drainage is failed [40] [41] [42] [43] [44] [45] [46] [47] [48] . Recently, VATS has been increasingly selected as an option for treatment of childhood empyema. Pediatric prospective studies showed that fibrinolytic therapy and VATS were equal to each other and there were not any differences in hospital stay, days with drainage, or treatment failure between the two treatment options [50] [51] [52] . In a pediatric retrospective case-control study, it was shown that VATS did not result in a significantly shorter hospital stay or fewer complications compared with the conservative approach of chest drainage with or without fibrinolysis 2 .
As a result of reviewing the four randomized controlled study involving 194 children, there is no evidence that VATS is more effective than fibrinolytic treatment and authors suggested that nonoperative management should be the first line of therapy, if feasible. If pleural space drainage with fibrinolytic therapy is ineffective, VATS should be performed without delay 53 . In our study, tube thoracostomy and antibiotic treatment was successful especially for most of the patients with empyema. When this treatment failed, intrapleural fibrinolysis was applied before VATS. Open decortication was reserved for all of these treatment failures.
We concluded that, patients with empyema were younger than the patients with PPE. Duration and frequency of fever were similar in patients with PPE or empyema, dyspnea is a more frequent presenting symptom of patients with empyema. S. pneumoniae and group A streptococcus had been detected as the most common causes of empyema, however pleural fluid culture positivity rate was low. M. pneumoniae might be responsible for PPE or empyema as a single pathogen. Furthermore M. pneumoniae related empyema might be as massive as requiring tube thoracostomy and intrapleural fibrinolysis. Adding macrolide antibiotic to initial beta-lactam antibiotics should be kept in mind in patients who show no improvement. Chest USG was a useful diagnostic imaging modality for PPE and empyema. Chest CT scan might be required to detect necrotizing pneumonia and lung abscesses. Tube thoracostomy and antibiotic treatment were successful treatment modalities for most of the patients.
